Home/Abera Bioscience/Joen Luirink
JL

Joen Luirink

Founder & CTO

Abera Bioscience

Therapeutic Areas

Abera Bioscience Pipeline

DrugIndicationPhase
Nasal Pneumococcal VaccinePneumococcal disease (serotype-independent)Pre-clinical
Nasal Influenza VaccineInfluenzaPre-clinical